Women's imaging vendor Hologic has completed its acquisition of Gen-Probe for a total net purchase price of approximately $3.8 billion, making Gen-Probe a wholly owned subsidiary.
The deal strengthens Hologic's growing diagnostics portfolio and advances its focus on women's health, according to the firm.
The closing follows Hologic's receipt of all necessary regulatory approvals, as well as approval of the transaction by Gen-Probe shareholders on July 31, Hologic said.
